Journal of Preventive Medicine and Public Health

  • 제43권1호
  • /
  • Pages.18-25
  • /
  • 2010
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지
DOI QR코드

DOI QR Code

농촌지역 고혈압 전단계 성인의 혈청 Gamma-Glutamyltransferase와 고혈압 발생률간의 관련성

Association Between Gamma-Glutamyltransferase and Hypertension Incidence in Rural Prehypertensive Adults

  • 황준현 (경북대학교 의학전문대학원 예방의학교실) ;
  • 신지연 (경북대학교 의학전문대학원 예방의학교실) ;
  • 천병렬 (경북대학교 건강증진연구소) ;
  • 이덕희 (경북대학교 의학전문대학원 예방의학교실) ;
  • 김건엽 (경북대학교 의학전문대학원 예방의학교실) ;
  • 박의현 (경북대학교 의학전문대학원 내과학교실) ;
  • 채성철 (경북대학교 의학전문대학원 내과학교실)
  • Hwang, Jun-Hyun (Department of Preventive Medicine, School of Medicine, Kyungpook National University) ;
  • Shin, Ji-Yeon (Department of Preventive Medicine, School of Medicine, Kyungpook National University) ;
  • Chun, Byung-Yeol (Health Promotion Research Center, Kyungpook National University) ;
  • Lee, Duk-Hee (Department of Preventive Medicine, School of Medicine, Kyungpook National University) ;
  • Kim, Keon-Yeop (Department of Preventive Medicine, School of Medicine, Kyungpook National University) ;
  • Park, Wee-Hyun (Department of Internal Medicine, School of Medicine, Kyungpook National University) ;
  • Chae, Shung-Chull (Department of Internal Medicine, School of Medicine, Kyungpook National University)
  • 발행 : 2010.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: Prehypertension is associated with a higher risk of developing hypertension compared with normotension. Yet, factors predicting the development of hypertension among prehypertensive people are ill-understood. This prospective cohort study was performed to examine if serum gamma-glutamyltrasferase (GGT) within a normal range can predict the future risk of hypertension among prehypertensive adults. Methods: Study subjects were 293 prehypertensive persons >30-years-of-age who participated in a community-based health survey in 2003 and who were followed up in 2008. Sex-specific quartiles of baseline serum GGT were used to examine association with 5-year hypertension incidence. Results: Baseline serum GGT within normal range predicted the risk of developing hypertension for 5 years only in prehypertensive women. Adjusted relative risks were 1.0, 3.7, 3.6, and 6.0 according to quartiles of baseline serum GGT (P for trend <0.01). This pattern was similarly observed in non-drinkers. However, serum GGT was not associated with incident hypertension in men. Different from serum GGT, baseline serum alanine aminotransferase, another well-known liver enzyme, did not predict the risk of incident hypertension in both genders. Conclusions: Even though baseline serum GGT within normal range strongly predicted the future risk of hypertension, it was observed only in women, Although underlying mechanisms of this association are currently unclear, serum GGT can be used to select a high risk group of hypertension in prehypertensive women.

키워드

참고문헌

  1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42(6): 1206-1252. https://doi.org/10.1161/01.HYP.0000107251.49515.c2
  2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289(19): 2560-2572. https://doi.org/10.1001/jama.289.19.2560
  3. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. The Third Korea National Health and Nutrition Examination Survey (KNHANES III) 2005: Health Examination. Seoul: Korea Centers for Disease Control and Prevention; 2006. (Korean)
  4. Winegarden CR. From "prehypertension"to hypertension- Additional evidence. Ann Epidemiol 2005; 15(9): 720-725. https://doi.org/10.1016/j.annepidem.2005.02.010
  5. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 2001; 358(9294): 1682-1686.
  6. Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991; 17(1): 22-27. https://doi.org/10.1161/01.HYP.17.1.22
  7. Pitsavos C, Chrysohoou C, Panagiotakos DB, Lentzas Y, Stefanadis C. Abdominal obesity and inflammation predicts hypertension among prehypertensive men and women: The ATTICA Study. Heart Vessels 2008; 23(2): 96-103. https://doi.org/10.1007/s00380-007-1018-5
  8. Teschke R, Brand A, Strohmeyer G. Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption. Biochem Biophys Res Commun 1977; 75(3): 718-724. https://doi.org/10.1016/0006-291X(77)91531-5
  9. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49(8): 1358-1366. https://doi.org/10.1373/49.8.1358
  10. Ikai E, Honda R, Yamada Y. Serum gamma-glutamyl transpeptidase level and blood pressure in nondrinkers: A possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens 1994; 8(2): 95-100.
  11. Lee DH, Ha MH, Kim JR, Gross M, Jacobs DR Jr. Gamma-glutamyltransferase, alcohol, and blood pressure. A four year follow-up study. Ann Epidemiol 2002; 12(2): 90-96. https://doi.org/10.1016/S1047-2797(01)00252-6
  12. Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP. Body fat distribution, liver enzymes, and risk of hypertension: Evidence from the Western New York study. Hypertension 2005; 46(5): 1186-1193. https://doi.org/10.1161/01.HYP.0000185688.81320.4d
  13. Shankar A, Li J. Association between serum gammaglutamyltransferase level and prehypertension among US adults. Circ J 2007; 71(10): 1567-1572. https://doi.org/10.1253/circj.71.1567
  14. Kawamoto R, Kohara K, Tabara Y, Kusunoki T, Otsuka N, Miki T. Association between serum gamma-glutamyl transferase level and prehypertension among communitydwelling men. Tohoku J Exp Med 2008; 216(3): 213-221. https://doi.org/10.1620/tjem.216.213
  15. Nilssen O, Forde OH, Brenn T. The Tromso Study. Distribution and population determinants of gammaglutamyltransferase. Am J Epidemiol 1990; 132(2): 318- 326. https://doi.org/10.1093/oxfordjournals.aje.a115661
  16. Yamada Y, Ishizaki M, Kido T, Honda R, Tsuritani I, Yamaya H. Relationship between serum gamma-glutamyl transpeptidase activity and blood pressure in middle-aged male and female non-drinkers. J Hum Hypertens 1990; 4(6): 609-614.
  17. Ikai E, Noborizaka Y, Tsuritani I, Honda R, Ishizaki M, Yamada Y. Serum gamma-glutamyl transpeptidase levels and hypertension in non-drinkers: A possible role of fatty liver in the pathogenesis of obesity related hypertension. Obes Res 1993; 1(6): 469-474. https://doi.org/10.1002/j.1550-8528.1993.tb00029.x
  18. Yamada Y, Ikai E, Tsuritani I, Ishizaki M, Honda R, Ishida M. The relationship between serum gamma-glutamyl transpeptidase levels and hypertension: Common in drinkers and nondrinkers. Hypertens Res 1995; 18(4): 295- 301. https://doi.org/10.1291/hypres.18.295
  19. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: The Bogalusa Heart Study. Metabolism 2007; 56(6): 792-798. https://doi.org/10.1016/j.metabol.2007.01.010
  20. Kim DJ, Noh JH, Cho NH, Lee BW, Choi YH, Jung JH, et al. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabet Med 2005; 22(9): 1134-1140. https://doi.org/10.1111/j.1464-5491.2005.01581.x
  21. Yokoyama H, Hirose H, Moriya S, Saito I. Significant correlation between insulin resistance and serum gammaglutamyl transpeptidase (gamma-GTP) activity in nondrinkers. Alcohol Clin Exp Res 2002; 26(8 Suppl): 91S- 94S.
  22. Ortega E, Koska J, Salbe AD, Tataranni PA, Bunt JC. Serum gamma-glutamyl transpeptidase is a determinant of insulin resistance independently of adiposity in Pima Indian children. J Clin Endocrinol Metab 2006; 91(4): 1419-1422. https://doi.org/10.1210/jc.2005-1783
  23. Simao AN, Dichi JB, Barbosa DS, Cecchini R, Dichi I. Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome. Nutrition 2008; 24(7-8): 675- 681 https://doi.org/10.1016/j.nut.2008.03.021
  24. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress- Free Radic Res 2004; 38(6): 535-539. https://doi.org/10.1080/10715760410001694026
  25. Lee DH, Jacobs DR Jr. Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants- Free Radic Res 2009; 43(6): 533-537. https://doi.org/10.1080/10715760902893324
  26. Lee DH, Steffes MW, Jacobs DR Jr. Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes- Diabetologia 2008; 51(3): 402-407. https://doi.org/10.1007/s00125-007-0896-5
  27. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study. Am J Hypertens 2004; 17(7): 568-573. https://doi.org/10.1016/j.amjhyper.2004.03.675
  28. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004; 164(19): 2113-2118. https://doi.org/10.1001/archinte.164.19.2113
  29. Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease. Am J Med 2006; 119(2): 133-141. https://doi.org/10.1016/j.amjmed.2005.08.023